Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    North America healthcare 3D printing industry summary, 2017-2028

2.1.1    Country trends

2.1.2    Product trends

2.1.3    Technology trends

2.1.4    Application trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2017-2028

3.3    Major factor analysis

3.3.1    Drivers

3.3.1.1   Technological advancements

3.3.1.2   Extended clinical applications

3.3.1.3   Increasing demand for custom implants

3.3.1.4   Increasing R&D investments from manufacturers and institutions

3.3.2    Industry pitfalls & challenges

3.3.2.1   Lack of skilled professionals

3.3.2.2. High price associated with 3 D printing

3.4    COVID-19 impact analysis

3.5    Porter's analysis

3.6    Competitive review, 2021

3.7    PESTEL analysis

Chapter 4   North America Healthcare 3D Printing Market, By Product

4.1    Key segment trends in North America healthcare 3D printing market, by product

4.2    Syringe based

4.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

4.3    Magnetic levitation

4.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

4.4    Laser based

4.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

4.5    Inkjet based

4.5.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

Chapter 5   North America Healthcare 3D Printing Market, By Technology

5.1    Key segment trends in North America healthcare 3D printing market, by technology

5.2    Fused deposition modelling (FDM)

5.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

5.3    Selective laser sintering (SLS)

5.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

5.4    Stereolithography

5.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

5.5    Others

5.5.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

Chapter 6   North America Healthcare 3D Printing Market, By Application

6.1    Key segment trend North America healthcare 3D printing market, by application

6.2    Biosensors

6.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

6.3    Medical

6.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

6.3.2    Pharmaceuticals

6.3.2.1   Market estimates and forecast, by country, 2017-2028 (USD Million)

6.3.3    Prosthetics and implants

6.3.3.1   Market estimates and forecast, by country, 2017-2028 (USD Million)

6.3.4    Tissue and organ generation

6.3.4.1   Market estimates and forecast, by country, 2017-2028 (USD Million)

6.4    Dental

6.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

Chapter 7   North America Healthcare 3D Printing Market, By Country

7.1    Key regional trends North America healthcare 3D printing market, by country

7.2    U.S.

7.2.1    Market estimates and forecast, by product, 2017-2028 (USD Million)

7.2.2    Market estimates and forecast, by technology, 2017-2028 (USD Million)

7.2.3    Market estimates and forecast, by application, 2017-2028 (USD Million)

7.2.3.1   Market estimates and forecast, by medical application, 2017-2028 (USD Million)

7.3    Canada

7.3.1    Market estimates and forecast, by product, 2017-2028 (USD Million)

7.3.2    Market estimates and forecast, by technology, 2017-2028 (USD Million)

7.3.3    Market estimates and forecast, by application, 2017-2028 (USD Million)

7.3.3.1   Market estimates and forecast, by medical application, 2017-2028 (USD Million)

Chapter 8   Company Profiles

8.1    3D Biotek

8.1.1    Business overview

8.1.2    Financial data

8.1.3    Product landscape

8.1.4    Strategic outlook

8.2    3D Systems

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.3    Aprecia Pharmaceuticals

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.4    Aspect Biosystems

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.5    BioBots

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.6    Digilab

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.7    Nano3D Biosciences

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.8    Organovo

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.9    Stratasys

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.10    TeVido BioDevices

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook